Bioventus products, orthobiologics, biologics and devices for bone healing and osteoartritis pain relief are known as innovations for active healing.
Location: United States, North Carolina, Durham
Investors 2
| Date | Name | Website |
| - | Alta Partn... | altapartne... |
| - | EW Healthc... | ewhealthca... |
Mentions in press and media 5
| Date | Title | Description |
| 19.07.2020 | Bioventus Makes $15 Million Equity Investment in CartiHeal | KFAR SABA, Israel & DURHAM, N.C.--(BUSINESS WIRE)--CartiHeal, developer of the proprietary Agili™-C implant for the treatment of joint surface lesions in traumatic and osteoarthritic joints, has secured an additional $15 million equity ... |
| 17.01.2019 | Bioventus launches Osteomatrix+ bone graft | Bioventus announced today that it has started selling Osteomatrix+ – a moldable bone graft substitute intended for a variety of orthopedic and spine bone remodeling applications. Bioventus officials boast that Osteomatrix+ has improved mold... |
| 01.02.2018 | CartiHeal Secures $2.5M in Funding | CartiHeal, a Kfar Saba, Israel-based developer of the proprietary Agili-C implant for the treatment of joint surface lesions in traumatic and osteoarthritic joints, secured $2.5M in funding. Bioventus made the investment, which complements ... |
| 01.07.2016 | 5 takeaways from Bioventus IPO move | What’s it for? Bioventus only provided a $150 million estimate for how much it intends to raise through the proposed IPO. But according to the offering documents, the money would be used to pay down debt some of the company’s $60 million de... |
| - | 5 takeaways from Bioventus IPO move | The medical technology company Bioventus jumped deeper into biotech’s tumultuous waters on Thursday by registering a $150 million initial public stock offering. Headquartered in Durham, North Carolina, Bioventus develops orthopedic products... |